Medicare Enrolled
Dr. Richard Siegel, MD
Hematology & Oncology · Arlington Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Siegel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siegel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Siegel
Dr. Richard Siegel is a hematology & oncology specialist in Arlington Heights, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Siegel performed 86,940 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Siegel received a total of $7,210 from 56 pharmaceutical and/or device companies across 327 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Siegel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in IL
$7,210 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗86,940
Medicare services
Top 12% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
20,100 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 18,400 | $43 | $137 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
13,400 | $0 | $33 |
| Denosumab injection (Prolia/Xgeva) | 6,360 | $18 | $67 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
4,810 | $2 | $20 |
| Paclitaxel chemotherapy injection | 4,062 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,389 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,246 | $8 | $35 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,943 | $19 | $144 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,732 | $8 | $19 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,560 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,430 | $0 | $24 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
828 | $82 | $1,348 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
741 | $67 | $168 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
704 | $13 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
571 | $101 | $231 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
521 | $107 | $686 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
510 | $2 | $13 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 477 | $3 | $373 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
396 | $2 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
379 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
236 | $23 | $152 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
233 | $66 | $157 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
194 | $35 | $139 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
183 | $1 | $13 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
173 | $60 | $205 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
164 | $4 | $29 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
158 | $54 | $334 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
153 | $7 | $431 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
146 | $1 | $17 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
145 | $2 | $19 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
145 | $73 | $70 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 122 | $135 | $3,675 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
111 | $11 | $73 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
107 | $52 | $304 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
105 | $26 | $249 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
102 | $1 | $7 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
92 | $99 | $232 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $23 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
77 | $27 | $141 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
69 | $14 | $108 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
67 | $61 | $289 |
| New patient office visit, complex (60-74 min) | 63 | $176 | $432 |
| Injection, leucovorin calcium, per 50 mg | 58 | $3 | $25 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
57 | $109 | $297 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
54 | $1 | $19 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
52 | $213 | $1,726 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
45 | $31 | $240 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
39 | $16 | $97 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
36 | $46 | $281 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $135 | $343 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
28 | $42 | $115 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $32 | $56 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
19 | $76 | $183 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $136 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.6% high complexity
88.3% medium
10.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,210
Total received (2018-2024)
Avg $1,030/year across 7 years
Top 35% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
327
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,818
2023
$1,684
2022
$1,242
2021
$300
2020
$290
2019
$1,068
2018
$807
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$400
PFIZER INC.
$138
Gilead Sciences, Inc.
$122
Merck Sharp & Dohme LLC
$116
ABBVIE INC.
$113
Aveo Pharmaceuticals, Inc.
$100
Astellas Pharma US Inc
$87
GlaxoSmithKline, LLC.
$74
AstraZeneca Pharmaceuticals LP
$71
E.R. Squibb & Sons, L.L.C.
$55
Exelixis Inc.
$53
Daiichi Sankyo Inc.
$44
Eisai Inc.
$44
SERVIER PHARMACEUTICALS LLC
$44
Deciphera Pharmaceuticals Inc.
$40
Celgene Corporation
$31
Janssen Biotech, Inc.
$31
Tempus AI, Inc
$30
TerSera Therapeutics LLC
$29
Pharmacosmos Therapeutics Inc.
$25
Incyte Corporation
$25
Dendreon Pharmaceuticals LLC
$24
GE HEALTHCARE
$23
Biocon Biologics Inc
$22
Mirati Therapeutics, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
PUMA BIOTECHNOLOGY, INC.
$19
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 36.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,122
PFIZER INC.
$637
Genentech USA, Inc.
$512
Janssen Biotech, Inc.
$424
Gilead Sciences, Inc.
$393
Merck Sharp & Dohme LLC
$282
Merck Sharp & Dohme Corporation
$278
Astellas Pharma US Inc
$245
Seagen Inc.
$244
E.R. Squibb & Sons, L.L.C.
$223
Amgen Inc.
$216
AstraZeneca Pharmaceuticals LP
$196
GlaxoSmithKline, LLC.
$194
Takeda Pharmaceuticals U.S.A., Inc.
$157
Adaptive Biotechnologies Corporation
$149
EMD Serono, Inc.
$127
Incyte Corporation
$116
GENZYME CORPORATION
$113
ABBVIE INC.
$113
G1 Therapeutics, Inc.
$106
Daiichi Sankyo Inc.
$103
SANOFI-AVENTIS U.S. LLC
$100
Aveo Pharmaceuticals, Inc.
$100
Pharmacyclics LLC, An AbbVie Company
$82
Exelixis Inc.
$79
AbbVie Inc.
$75
Deciphera Pharmaceuticals Inc.
$65
Celgene Corporation
$65
Eisai Inc.
$44
SERVIER PHARMACEUTICALS LLC
$44
CTI BioPharma Corp.
$42
JAZZ PHARMACEUTICALS INC.
$40
Janssen Pharmaceuticals, Inc
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Tempus AI, Inc
$30
TerSera Therapeutics LLC
$29
Pharmacosmos Therapeutics Inc.
$25
PharmaEssentia USA Corporation
$25
Dendreon Pharmaceuticals LLC
$24
GE HEALTHCARE
$23
Biocon Biologics Inc
$22
Mirati Therapeutics, Inc.
$22
EISAI INC.
$22
Regeneron Healthcare Solutions, Inc.
$21
MorphoSys, US Inc.
$21
Apellis Pharmaceuticals, Inc.
$20
Puma Biotechnology, Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$19
BeiGene USA, Inc.
$18
AMAG Pharmaceuticals, Inc.
$18
Secura Bio, Inc.
$18
Agios Pharmaceuticals, Inc.
$18
Array BioPharma Inc.
$16
ADC Therapeutics America, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Sysmex Inostics Inc
$13
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
Alecensa · Avastin · BAVENCIO · BESREMI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CHANTIX · COPIKTRA · COSELA · CREON · DARZALEX · ELIQUIS · EMEND · ENHERTU · ERLEADA · Empaveli · Enhertu · Erleada · FERAHEME · FOTIVDA · Fabhalta · Fulphila · GAUCHER-DISEASE · GILOTRIF · HYQVIA · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · LENVIMA · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYLOTARG · Nplate · OJJAARA · OPDIVO · OPDUALAG · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · RYBREVANT · SANDOSTATIN · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tibsovo · Trodelvy · VENCLEXTA · VOTRIENT · VYXEOS · Vanflyta · Vonjo · XALKORI · XARELTO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
278
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWEST COMMUNITY HOSPITAL 1
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Siegel is a mixed practice specialist, with above-average Medicare volume (top 12% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Siegel experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Siegel performed 20,100 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Siegel receive payments from pharmaceutical companies?
Yes. Dr. Siegel received a total of $7,210 from 56 companies across 327 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siegel's costs compare to other hematology & oncology specialists in Arlington Heights?
Dr. Siegel's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siegel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Arlington Heights
Browse hematology & oncology specialists in Arlington Heights ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology